Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,933 GBX | +0.05% | -4.59% | +8.16% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
ETFs positioned on Hikma Pharmaceuticals PLC
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,083 M€ | +4.63% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - | |
0.16% | 17 M€ | +8.99% | - | |
0.15% | 5 M€ | +10.09% | - | |
0.15% | 14 M€ | +5.66% | - | |
0.04% | 6 M€ | -.--% | ||
0.02% | 10 M€ | -3.35% | - | |
0.01% | 32 M€ | +8.70% | - | |
0.01% | 284 M€ | -.--% | ||
0.01% | 206 M€ | -.--% | ||
0.01% | 1,166 M€ | +0.26% | - | |
0.01% | 607 M€ | +0.05% | - | |
0.01% | 23 M€ | -.--% | - | |
0.01% | 786 M€ | -.--% | ||
0.01% | 283 M€ | +21.63% | ||
0.00% | 391 M€ | +9.37% | - | |
0.00% | 34 M€ | +4.77% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 34 M€ | +9.34% | - | |
0.00% | 234 M€ | +7.12% | - | |
0.00% | 306 M€ | +6.54% | - | |
0.00% | 39 M€ | +6.45% | - | |
0.00% | 25 M€ | -2.62% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.16% | 5.45B | |
+37.78% | 723B | |
+30.64% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.06% | 244B | |
-5.03% | 208B | |
+9.84% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- HIK Stock
- Funds and ETFs Hikma Pharmaceuticals PLC